Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This randomized, controlled, double-blind study evaluates the utility of alpha-lipoic acid and silybum marianum , versus placebo, in the treatment of metabolic associated fatty liver disease.
Epistemonikos ID: e7dcf3e081be04c0ef2281800384f2ca8c231ada
First added on: May 15, 2024